Citation: J. Carman et al., RISPERIDONE IN THE TREATMENT OF NEGATIVE SYMPTOMS OF SCHIZOPHRENIA - A METAANALYSIS, International clinical psychopharmacology, 10(4), 1995, pp. 207-213
Citation: J. Peuskens, RISPERIDONE IN THE TREATMENT OF PATIENTS WITH CHRONIC-SCHIZOPHRENIA -A MULTI-NATIONAL, MULTICENTER, DOUBLE-BLIND, PARALLEL-GROUP STUDY VERSUS HALOPERIDOL, British Journal of Psychiatry, 166, 1995, pp. 712-726
Citation: J. Peuskens, PEER-REVIEW OF RISPERIDONE IN THE TREATMENT OF PATIENTS WITH CHRONIC-SCHIZOPHRENIA - A MULTI-NATIONAL, MULTICENTER, DOUBLE-BLIND, PARALLEL-GROUP STUDY VERSUS HALOPERIDOL - RESPONSE, British Journal of Psychiatry, 166, 1995, pp. 731-733
Authors:
ZAMANI MG
DEHERT M
SPAEPEN M
HERMANS M
MARYNEN P
CASSIMAN JJ
PEUSKENS J
Citation: Mg. Zamani et al., STUDY OF THE POSSIBLE ASSOCIATION OF HLA CLASS-II, CD4, AND CD3 POLYMORPHISMS WITH SCHIZOPHRENIA, American journal of medical genetics, 54(4), 1994, pp. 372-377